[go: up one dir, main page]

ES2176702T3 - Antimicoticos con alta liberacion de sustancia activa. - Google Patents

Antimicoticos con alta liberacion de sustancia activa.

Info

Publication number
ES2176702T3
ES2176702T3 ES97909278T ES97909278T ES2176702T3 ES 2176702 T3 ES2176702 T3 ES 2176702T3 ES 97909278 T ES97909278 T ES 97909278T ES 97909278 T ES97909278 T ES 97909278T ES 2176702 T3 ES2176702 T3 ES 2176702T3
Authority
ES
Spain
Prior art keywords
antimicotics
active substance
high release
release
micosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97909278T
Other languages
English (en)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Astrid Markus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7807116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2176702(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Application granted granted Critical
Publication of ES2176702T3 publication Critical patent/ES2176702T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

UNA PREPARACION FARMACEUTICA, QUE CONTIENE UN GELIFICANTE HIDROFILICO, AGUA Y UN COMPUESTO DE FORMULA (I) QUE ES APROPIADO PARA EL TRATAMIENTO Y PREVENCION DE MICOSIS CUTANEAS
ES97909278T 1996-09-27 1997-09-16 Antimicoticos con alta liberacion de sustancia activa. Expired - Lifetime ES2176702T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19639816A DE19639816A1 (de) 1996-09-27 1996-09-27 Antimykotische Mittel mit hoher Wirkstofffreisetzung

Publications (1)

Publication Number Publication Date
ES2176702T3 true ES2176702T3 (es) 2002-12-01

Family

ID=7807116

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97909278T Expired - Lifetime ES2176702T3 (es) 1996-09-27 1997-09-16 Antimicoticos con alta liberacion de sustancia activa.

Country Status (34)

Country Link
US (3) US7018656B2 (es)
EP (1) EP0928192B1 (es)
JP (1) JP2001501609A (es)
KR (1) KR100457850B1 (es)
CN (1) CN1149992C (es)
AR (1) AR008858A1 (es)
AT (1) ATE216882T1 (es)
AU (1) AU718837B2 (es)
BG (1) BG63864B1 (es)
BR (1) BR9711559A (es)
CA (1) CA2267160C (es)
CY (1) CY2371B1 (es)
CZ (1) CZ291170B6 (es)
DE (2) DE19639816A1 (es)
DK (1) DK0928192T3 (es)
ES (1) ES2176702T3 (es)
HU (1) HU228297B1 (es)
ID (1) ID22149A (es)
IL (1) IL129140A (es)
MA (1) MA24331A1 (es)
MY (1) MY117863A (es)
NO (1) NO321899B1 (es)
NZ (1) NZ334849A (es)
OA (1) OA11026A (es)
PL (1) PL188840B1 (es)
PT (1) PT928192E (es)
RS (1) RS49596B (es)
RU (1) RU2181281C2 (es)
SI (1) SI0928192T1 (es)
TR (1) TR199900723T2 (es)
TW (1) TW558442B (es)
UA (1) UA52699C2 (es)
WO (1) WO1998013042A1 (es)
ZA (1) ZA978638B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
JPWO2003105903A1 (ja) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 抗真菌医薬組成物
CN100425233C (zh) * 2005-01-12 2008-10-15 复旦大学 一种鼻腔用尼莫地平凝胶剂
US20080176908A1 (en) * 2007-01-18 2008-07-24 Mcanally Weylan R Method of using squalene monooxygenase inhibitors to treat acne
MX2007009796A (es) * 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
WO2010069519A1 (en) 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7
US8618175B2 (en) * 2010-07-19 2013-12-31 Brussels Ventures Corp. Ultrasound medical gel composition etherified hydroxyethylcellulose
CN105797696A (zh) * 2016-03-23 2016-07-27 广东省工程技术研究所 一种分子印迹整体柱的制备方法
KR102166485B1 (ko) * 2018-04-12 2020-10-15 숙명여자대학교산학협력단 식품 신선도 유지를 위한 항균성 하이드로겔

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL156397B (nl) * 1968-08-31 1978-04-17 Hoechst Ag Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.
US3968118A (en) 1968-08-31 1976-07-06 Hoechst Aktiengesellschaft Process for the manufacture of 1-hydroxy-2-pyridones
US4185106A (en) 1972-07-11 1980-01-22 Hoechst Aktiengesellschaft Pyridones as antidandruff agents
DE3140954A1 (de) 1981-10-15 1983-05-05 Hoechst Ag "verwendung von 1-hydroxy-2-pyridonen zur prophylaxe und behandlung von akne"
GB8302683D0 (en) 1983-02-01 1983-03-02 Unilever Plc Skin treatment composition
JPS6169721A (ja) 1984-09-13 1986-04-10 Kao Corp 抗真菌組成物
GB8524508D0 (en) 1985-10-04 1985-11-06 Beecham Group Plc Composition
JPH01501143A (ja) 1985-11-04 1989-04-20 ダ−マトロジカル・プロダクツ・オブ・テキサス 爪への薬物の施用のための皮膜形成性製剤用ヴェヒクル、これらのヴェヒクルを基にした薬剤組成物および同じものの使用法
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
EP0241918B1 (de) 1986-04-18 1992-05-27 Hoechst Aktiengesellschaft 1-Hydroxy-2-pyridone, Verfahren zu ihrer Herstellung und Arzneimittel, die sie enthalten, sowie bei der Herstellung der 1-Hydroxy-2-pyridone gebildete Zwischenprodukte
NL8601762A (nl) 1986-07-07 1988-02-01 Bouke Jan Lange Werkwijze voor de reiniging en conditionering en eventuele medicinale behandeling van het haar en de hoofdhuid, een voor dit doel bruikbare tweefasen shampoo, alsmede een verpakking daarvoor.
JPS63230640A (ja) * 1987-03-19 1988-09-27 Shiseido Co Ltd 経皮吸収促進剤及びこれを含有する皮膚外用製剤
US5641475A (en) 1987-05-15 1997-06-24 Tristrata, Inc. Antiodor, antimicrobial and preservative compositions and methods of using same
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
LU86945A1 (fr) * 1987-07-17 1989-03-08 Oreal Compositions pharmaceutiques et cosmetiques a base de pyridones et d'agents antibacteriens
LU86944A1 (fr) 1987-07-17 1989-03-08 Oreal Composition a base de derives d'hydroxypyridone pour diminuer la chute des cheveux
JPS6468327A (en) * 1987-09-08 1989-03-14 Teisan Seiyaku Kk Warming type insulin-containing plaster
EP0496433B1 (en) 1987-10-22 1999-03-24 The Procter & Gamble Company Photoprotection compositions comprising chelating agents
WO1993012762A1 (fr) * 1988-03-22 1993-07-08 Yoshikazu Soyama Preparation destinee au soin des ongles
HU202098B (en) 1988-08-05 1991-02-28 Istvan Laczko Nail polish remover without aceton
DE3826914A1 (de) * 1988-08-09 1990-02-15 Henkel Kgaa Farbstabilisierung von antimikrobiellen zubereitungen
US5116603A (en) 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
JPH03120230A (ja) * 1989-10-04 1991-05-22 Nippon Mining Co Ltd 薬効成分の経皮吸収促進剤及び経皮吸収型製剤
JPH0623087B2 (ja) 1989-10-09 1994-03-30 花王株式会社 洗浄剤組成物
FR2653123B1 (fr) 1989-10-17 1992-01-17 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5066484A (en) 1990-04-30 1991-11-19 Revlon, Inc. Nail enamels containing glyceryl, glycol or citrate esters
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
FR2685638A1 (fr) 1991-12-31 1993-07-02 Biorga Sa Laboratoires Compositions pour l'usage cosmetique et/ou dermatologique, comprenant une association de pyrithione zinc, de piroctone olamine, et d'un derive de collagene et d'acide gras.
FR2685867B1 (fr) 1992-01-07 1995-06-09 Thorel Jean Compositions contre la desquamation de l'epiderme et du cuir chevelu.
DE4212105A1 (de) 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
FR2694694B1 (fr) 1992-08-13 1994-10-28 Thorel Jean Noel Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu.
AU5096393A (en) 1992-09-08 1994-03-29 Procter & Gamble Company, The Mild, substantially colorless shampoo composition
FR2697749B1 (fr) 1992-11-12 1995-01-13 Oreal Composition cosmétique filmogène à base d'un copolymère chloré greffé résultant du greffage d'une polyoléfine chlorée et de monomères insaturés du type acrylique, styrénique et/ou vinylique.
DE4333893A1 (de) 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
DE19518262A1 (de) 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
JP2945244B2 (ja) * 1993-05-24 1999-09-06 帝三製薬株式会社 酢酸ビニール系粘着剤を用いた硝酸イソソルビド含有貼付剤
FR2706299B1 (fr) * 1993-06-10 1995-09-01 Oreal Emulsion cosmétique ou dermatologique huile-dans-eau contenant une composition auto-émulsionnable à base d'un alcool gras et d'un alkylpolyoside et un co-émulsionnant.
WO1995006482A1 (en) * 1993-09-01 1995-03-09 Teijin Limited 1α,24-(OH)2-VITAMIN D3 EMULSION COMPOSITION
US5424435A (en) 1993-10-18 1995-06-13 Olin Corporation 1-hydroxy-6-substituted-2-pyridones
DE4336434A1 (de) 1993-10-26 1995-04-27 Hoechst Ag Pharmazeutische Zubereitung für die parenterale, enterale und dermale Verabreichung von praktisch unlöslichen Arzneistoffen und Verfahren zu ihrer Herstellung
US5480904A (en) 1993-10-28 1996-01-02 Eli Lilly And Company Methods for inhibiting uterine fibrosis
WO1995017165A2 (en) 1993-12-23 1995-06-29 The Procter & Gamble Company Tissue moisturizing and antimicrobial compositions
JP3629283B2 (ja) * 1994-02-15 2005-03-16 ポーラ化成工業株式会社 皮膚外用剤
FR2718349B1 (fr) 1994-04-07 1996-05-31 Oreal Compositions cosmétiques à appliquer sur l'ongle.
JPH07325488A (ja) 1994-04-08 1995-12-12 Nippon Steel Corp 画像形成方法及び画像形成装置
FR2719481B1 (fr) * 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
FR2722689B1 (fr) 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant
JPH08165244A (ja) * 1994-10-12 1996-06-25 Taisho Pharmaceut Co Ltd 皮膚疾患治療剤
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
IL113057A (en) 1995-03-21 1999-01-26 Univ Ramot Compositions for the treatment of dandruff
US5609854A (en) * 1995-06-06 1997-03-11 Elizabeth Arden Company, Division Of Conopco, Inc. Thickened and stabilized cosmetic emulsion compositions
DE19643831A1 (de) * 1996-10-30 1998-05-07 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von schwer therapierbaren Schleimhauterkrankungen
EP0865278B1 (de) 1995-12-04 2002-05-15 Aventis Pharma Deutschland GmbH Verwendung von 1-hydroxy-2-pyridonen zur behandlung von schwer therapierbaren schleimhauterkrankungen
DE19639817A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen
DE19639818A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20040039030A1 (en) * 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
EP0983037B1 (en) 1998-02-09 2003-05-02 MacroChem Corporation Antifungal nail lacquer
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel

Also Published As

Publication number Publication date
PL188840B1 (pl) 2005-05-31
HK1022268A1 (en) 2000-08-04
CA2267160A1 (en) 1998-04-02
HUP9903804A3 (en) 2003-05-28
ID22149A (id) 1999-09-09
PL332604A1 (en) 1999-09-27
PT928192E (pt) 2002-10-31
US20060121118A1 (en) 2006-06-08
CY2371B1 (en) 2004-06-04
EP0928192A1 (de) 1999-07-14
NZ334849A (en) 2000-09-29
DK0928192T3 (da) 2002-08-19
CZ107399A3 (cs) 1999-07-14
MA24331A1 (fr) 1998-04-01
DE19639816A1 (de) 1998-04-02
IL129140A0 (en) 2000-02-17
EP0928192B1 (de) 2002-05-02
BG63864B1 (bg) 2003-04-30
US20040081677A1 (en) 2004-04-29
DE59707169D1 (de) 2002-06-06
CN1149992C (zh) 2004-05-19
WO1998013042A1 (de) 1998-04-02
BG103262A (en) 1999-09-30
ZA978638B (en) 1998-03-27
NO321899B1 (no) 2006-07-17
KR100457850B1 (ko) 2004-11-18
CN1231609A (zh) 1999-10-13
TW558442B (en) 2003-10-21
HUP9903804A1 (hu) 2000-03-28
AU4703797A (en) 1998-04-17
MY117863A (en) 2004-08-30
YU13599A (sh) 2002-03-18
RS49596B (sr) 2007-06-04
RU2181281C2 (ru) 2002-04-20
ATE216882T1 (de) 2002-05-15
JP2001501609A (ja) 2001-02-06
IL129140A (en) 2004-08-31
SI0928192T1 (en) 2002-08-31
HU228297B1 (en) 2013-03-28
NO991458L (no) 1999-03-25
AR008858A1 (es) 2000-02-23
US7018656B2 (en) 2006-03-28
OA11026A (fr) 2003-03-10
TR199900723T2 (xx) 1999-07-21
CA2267160C (en) 2006-10-31
UA52699C2 (uk) 2003-01-15
KR20000048620A (ko) 2000-07-25
US20030190340A1 (en) 2003-10-09
US7026337B2 (en) 2006-04-11
NO991458D0 (no) 1999-03-25
BR9711559A (pt) 1999-08-24
AU718837B2 (en) 2000-04-20
CZ291170B6 (cs) 2003-01-15

Similar Documents

Publication Publication Date Title
MX9604354A (es) Nueva forma de dosis farmaceutica oral.
AU602874B2 (en) Medicament depot
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
GB2303850B (en) Metalloproteinase inhibitors
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
EP1776954A3 (en) The use of inhibitors of the renin-angiotensin system for the treatment of stroke
DK261490D0 (da) New pharmaceutical compound
ES2078567T3 (es) Preparados farmaceuticos y utilizacion de los oligo-sacaridos para la elaboracion de dichos preparados.
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
FI955260A7 (fi) Transdermaalisia terapeuttisia systeemejä serotoniiniagonistien antami sta varten
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan
AR004330A1 (es) Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
ES2170377T3 (es) Composicion que contiene quitosana.
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
KR970704442A (ko) 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
AU4944899A (en) New pharmaceutically active compounds
ES2184121T3 (es) Formulacion para el tratamiento y/o profilaxis de la demencia.
ATE74505T1 (de) Schmerzpraeparat.
NO991047D0 (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol
ES2139382T3 (es) Sistema terapeutico percutaneo para compuestos de silatran.
ECSP951483A (es) Heteroaril--oxazolidinonas de 5 eslabones que contienen nitrogeno
IT1276751B1 (it) Composti ad attivita' antitumorale